News-Medical.Net on MSN17h
Semaglutide improves maximal walking distance in people with symptomatic PAD and Type 2 diabetes
Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...
European Medical Journal1h
Predictive Model Optimises Treatment Selection for Type 2 Diabetes
Discover how a new model uses clinical data to predict the best glucose-lowering therapy for type 2 diabetes, enhancing ...